Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | colony stimulating factor 1 receptor | Starlite/ChEMBL | References |
Mus musculus | colony stimulating factor 1 receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | macrophage colony stimulating factor 1 receptor | Get druggable targets OG5_132967 | All targets in OG5_132967 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | neuroglian | 0.0033 | 0.0186 | 0.0077 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Echinococcus multilocularis | Immunoglobulin | 0.0033 | 0.0186 | 0.0123 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0186 | 0.0295 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Schistosoma mansoni | cell adhesion molecule | 0.0037 | 0.0225 | 0.012 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0739 | 0.6285 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0186 | 0.0295 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0739 | 0.6285 | 0.5 |
Schistosoma mansoni | vesicular amine transporter | 0.0033 | 0.0186 | 0.0079 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Loa Loa (eye worm) | melatonin receptor type 1A | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Loa Loa (eye worm) | unidentified vitellogenin-linked transcript protein 6 | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0739 | 0.6285 | 0.5 |
Loa Loa (eye worm) | gonadotropin-releasing hormone receptor 2 | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Schistosoma mansoni | amine GPCR | 0.1138 | 0.9728 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0739 | 0.6285 | 0.5 |
Loa Loa (eye worm) | G-protein-linked acetylcholine receptor protein 2 | 0.0024 | 0.011 | 0.0175 |
Echinococcus multilocularis | neuroglian | 0.0033 | 0.0186 | 0.0123 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0739 | 0.6285 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0186 | 0.0295 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0739 | 0.6285 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0739 | 0.6285 | 1 |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.0024 | 0.011 | 0.5 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.004 | 0.0251 | 0.0228 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.0033 | 0.0186 | 0.0123 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Trypanosoma brucei | protein kinase, putative | 0.0739 | 0.6285 | 0.5 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Echinococcus granulosus | Immunoglobulin | 0.0033 | 0.0186 | 0.0077 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0739 | 0.6285 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0186 | 0.0295 |
Brugia malayi | hypothetical protein | 0.0033 | 0.0186 | 0.0123 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0739 | 0.6285 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0033 | 0.0186 | 0.0123 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0739 | 0.6285 | 0.5 |
Brugia malayi | MAP kinase sur-1 | 0.0739 | 0.6285 | 1 |
Loa Loa (eye worm) | G-protein coupled receptor | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.004 | 0.0251 | 0.0399 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0739 | 0.6285 | 1 |
Echinococcus granulosus | twitchin | 0.0039 | 0.0243 | 0.0135 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0033 | 0.0186 | 0.0079 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0033 | 0.0186 | 0.0079 |
Loa Loa (eye worm) | G-protein coupled receptor | 0.0024 | 0.011 | 0.0175 |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.0024 | 0.011 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0225 | 0.0358 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0739 | 0.6285 | 0.6244 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0739 | 0.6285 | 0.5 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0739 | 0.6285 | 0.6244 |
Loa Loa (eye worm) | 5-hydroxytryptamine 2C receptor | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | TYRA-2 protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0037 | 0.0225 | 0.0117 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Echinococcus multilocularis | roundabout 2 | 0.0037 | 0.0225 | 0.0187 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0225 | 0.0358 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0739 | 0.6285 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0186 | 0.0295 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Echinococcus granulosus | defective proboscis extension response | 0.0033 | 0.0186 | 0.0077 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0739 | 0.6285 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | neuropeptide F receptor | 0.0024 | 0.011 | 0.0175 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0033 | 0.0186 | 0.0123 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Schistosoma mansoni | nephrin | 0.0033 | 0.0186 | 0.0079 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0186 | 0.0295 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Loa Loa (eye worm) | neuropeptide F receptor | 0.0024 | 0.011 | 0.0175 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0739 | 0.6285 | 0.5 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0739 | 0.6285 | 0.5 |
Onchocerca volvulus | 0.0024 | 0.011 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0225 | 0.0358 |
Echinococcus granulosus | roundabout 2 | 0.0037 | 0.0225 | 0.0117 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0739 | 0.6285 | 0.642 |
Echinococcus multilocularis | Immunoglobulin | 0.0033 | 0.0186 | 0.0123 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.011 | 0.0175 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | Inhibition of KIT in human Mo7e cells assessed as inhibition of SCF-dependent cell proliferation | ChEMBL. | 24138939 | |
IC50 (binding) | = 1.7 nM | Inhibition of FMS (unknown origin) | ChEMBL. | 24138939 |
IC50 (binding) | = 1.7 nM | BindingDB_Patents: Fluorescence Polarization Competition Assay. A fluorescence polarization competition immunoassay was used to measure compound inhibition of CSF-1R phosphorylation of tyrosine on a synthetic CSF-1R555-568 peptide (SYEGNSYTFIDPTQ). The assay was performed in black 96-well microplates (Cat #42-000-0117, Molecular Devices, Sunnyvale, Calif.). To each well, 5 µL of compound (in 4% DMSO) were mixed with 2 µL of 3.5 nM CSF-1R, 25 mM MgCl2 in assay buffer (100 mM HEPES (hydroxyethylpiperazineethylsodiumsulfonate), pH 7.5, 1 mM DTT (dithiothreitol), 0.01% Tween-20), and 2 µL of 1540 µM peptide in assay buffer. The kinase reaction was initiated by adding 1 µL of 10 mM ATP in assay buffer. The final concentrations in the 10 uL reaction mixture were 100 mM HEPES, pH 7.5, 1 mM DTT, 0.01% Tween-20, 2% DMSO, 308 µM SYEGNSYTFIDPTQ, 1 mM ATP, 5 mM MgCl2, and 0.7 nM CSF-1R. | ChEMBL. | No reference |
IC50 (binding) | = 1.7 nM | BindingDB_Patents: Fluorescence Polarization Competition Assay. A fluorescence polarization competition immunoassay was used to measure compound inhibition of CSF-1R phosphorylation of tyrosine on a synthetic CSF-1R555-568 peptide (SYEGNSYTFIDPTQ). The assay was performed in black 96-well microplates (Cat #42-000-0117, Molecular Devices, Sunnyvale, Calif.). To each well, 5 µL of compound (in 4% DMSO) were mixed with 2 µL of 3.5 nM CSF-1R, 25 mM MgCl2 in assay buffer (100 mM HEPES (hydroxyethylpiperazineethylsodiumsulfonate), pH 7.5, 1 mM DTT (dithiothreitol), 0.01% Tween-20), and 2 µL of 1540 µM peptide in assay buffer. The kinase reaction was initiated by adding 1 µL of 10 mM ATP in assay buffer. The final concentrations in the 10 uL reaction mixture were 100 mM HEPES, pH 7.5, 1 mM DTT, 0.01% Tween-20, 2% DMSO, 308 µM SYEGNSYTFIDPTQ, 1 mM ATP, 5 mM MgCl2, and 0.7 nM CSF-1R. | ChEMBL. | No reference |
IC50 (binding) | = 1.7 nM | Fluorescence Polarization Competition Immunoassay | BINDINGDB. | No reference |
IC50 (binding) | = 25 nM | Inhibition of FMS in mouse BMDM cells | ChEMBL. | 24138939 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.